Generics and Biosimilar Medicines Deliver More Savings Every Year | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard interviews pharmaceutical industry veteran Bob Billings

Generics and Biosimilar Medicines Deliver More Savings Every Year

At a moment when policymakers are contemplating measures to reduce drug prices for America’s patients, AAM’s 2021 U.S. Generic and Biosimilar Medicines Savings Report, featuring data from IQVIA, breaks the savings down by state, age, payer, common medical conditions and more.

Because tens of millions of Americans entrust their health to generics and biosimilars, they saved $338 billion in 2020, and nearly $2.4 trillion in the last decade.

Some key figures:

  • In 2020, generic medicines fill nine out of every ten U.S. prescriptions, but account for only 18% of all drug spending.
  • 93% of generic prescriptions are filled at $20 or less.
  • U.S. biosimilars savings totaled $8 billion in 2020 and $133 billion over the past 10 years.

Download Fact Sheet

2021 Savings Report

Issues

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.